Skip to product information
1 of 1

NSJ Bioreagents

SKU:V9306-100UG

Recombinant AMACR / p504S Antibody (Prostate Cancer Marker), 100 ug

Recombinant AMACR / p504S Antibody (Prostate Cancer Marker), 100 ug

Regular price $559.00 USD
Regular price Sale price $559.00 USD
Sale Sold out
Shipping calculated at checkout.
Size

This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma.

Specifications

Catalog No V9306-100UG
Family Primary antibody
Qty 100 ug
Formulation 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Format Purified
Clone rAMACR/6369
Host Animal Mouse
Clonality Recombinant Mouse Monoclonal
Isotype Mouse IgG2a, kappa
Species Reactivity Human
Application WB, IHC-P
Application Details Western blot: 1-2ug/ml,Immunohistochemistry (FFPE): 1-2ug/ml
Application Note Optimal dilution of the recombinant AMACR antibody should be determined by the researcher.
Localization Cytoplasmic
Immunogen Recombinant full-length human AMACR protein was used as the immunogen for the recombinant AMACR antibody.
Purity Protein A/G affinity
Storage Aliquot the recombinant AMACR antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitation This recombinant AMACR antibody is available for research use only.
Uniprot # Q9UHK6
Status Available
PDF Link https://www.nsjbio.com/tds-pdf/recombinant-amacr-p504s-antibody-prostate-cancer-marker-ramacr6369-v9306
Title Recombinant AMACR / p504S Antibody (Prostate Cancer Marker)
Description This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma.
View full details